UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End
(Update corrects headline to say COO to step down, not CEO)
Athenahealth (NASDAQ: ATHN) reported Q2 EPS of $0.34, $0.08 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $261.9 million versus the consensus estimate of $274.07 million.
GUIDANCE:
Athenahealth sees FY2016 EPS of $1.65-$1.85, versus the consensus of $1.80. Athenahealth sees FY2016 revenue of $1.085-1.115 billion, versus the consensus of $1.12 billion.
- We expect GAAP Total Revenue to be at or above the mid-point of the $1,085 million to $1,115 million guidance range.
- We expect Non-GAAP Adjusted Gross Margin to be at or above the mid-point of the 63.5% to 64.5% guidance range.
- We expect Non-GAAP Adjusted Operating Income to be at or above the mid-point of the $120 million to $135 million guidance range.
- Finally, we expect Non-GAAP Adjusted Net Income per Diluted Share to be at or above the mid-point of the $1.65 to $1.85 guidance range.
The company also announced that chief operating officer Ed Park will begin a yearend transition from his current role and is expected to thereafter be elected to the board of directors.
For earnings history and earnings-related data on Athenahealth (ATHN) click here.